MiNK Therapeutics, Inc.·4

Mar 5, 4:05 PM ET

Ryan Barbara 4

4 · MiNK Therapeutics, Inc. · Filed Mar 5, 2025

Insider Transaction Report

Form 4
Period: 2025-03-03
Ryan Barbara
Director
Transactions
  • Award

    Common Stock

    2025-03-03$8.79/sh+2,019$17,74717,048 total
Footnotes (1)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs were received in lieu of cash retainers for board and committee compensation. The RSUs will vest one month from the grant date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4